Patent Assignment
Reel/Frame 069094/0417
Change of Name
Recorded: 2024-10-01
Pages: 4
Assignor
BOSTON BIOMEDICAL, INC.
Executed: 2020-07-01
Assignee
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Application:
18/741,526 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →
Assignment of Assignor's Interest
Oct 1, 2024
From: XU, YONG; BRENNING, BENJAMIN GARY; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 069094/0247 →
Change of Name
Oct 1, 2024
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 069094/0505 →
Merger
Oct 1, 2024
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 068758/0057 →
Merger
Oct 1, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068758/0193 →